Related Experiment Videos
Coronary artery disease in Chinese males without hypercholesterolaemia
Insights
This study found that even with normal cholesterol, altered triglyceride and HDL-cholesterol levels are key risk factors for coronary artery disease (CAD) in men. These metabolic changes contribute significantly to CAD development.
Area of Science:
- Cardiology
- Metabolic Syndrome
- Lipidology
Background:
- Coronary artery disease (CAD) is a leading cause of mortality.
- Identifying metabolic risk factors beyond traditional markers like high cholesterol is crucial for effective prevention and treatment strategies.
Purpose of the Study:
- To investigate the prevalence of metabolic risk factors for CAD in a cohort of male patients.
- To explore the role of lipid and lipoprotein profiles in patients with CAD and cholesterol levels below 5.2 mmol l-1.
Main Methods:
- Analysis of 246 male patients over a 2-year period.
- Diagnosis of CAD based on clinical history, electrocardiogram, and coronary angiography.
- Comparison of plasma lipid and lipoprotein levels between CAD patients (cholesterol < 5.2 mmol l-1) and a control group.
Main Results:
- 38% of patients had diabetes, hypertension, or both.
- Among those without diabetes or hypertension, 39% had cholesterol > 5.2 mmol l-1 and 23% had cholesterol < 5.2 mmol l-1.
- CAD patients with cholesterol < 5.2 mmol l-1 showed increased triglycerides and decreased HDL-cholesterol.
Conclusions:
- Elevated triglycerides and reduced HDL-cholesterol are significant contributors to CAD, even in the absence of hypercholesterolemia, diabetes, or hypertension.
- These findings highlight the importance of comprehensive lipid profiling in assessing cardiovascular risk.
- Metabolic dysregulation of triglycerides and HDL-cholesterol plays a major role in CAD pathogenesis.
Abstract:
The aim of this study was to determine the frequency of various metabolic risk factors for coronary artery disease (CAD) in 246 male patients studied over a 2-year period. CAD was diagnosed on the basis of a history indicative of angina pectoris, an electrocardiogram diagnostic of myocardial ischaemia, and a positive coronary angiogram. Thirty-eight per cent of this population had diabetes, hypertension or both. Of the remaining individuals, 39% had a plasma cholesterol concentration greater than 5.2 mmol l-1, whereas 23% had a cholesterol concentration less than 5.2 mmol l-1. Plasma lipid and lipoprotein levels of a non-smoking subset of those subjects with a total cholesterol concentration less than 5.2 mmol l-1 were compared with values of a matched group of individuals who did not have significant vessel disease as revealed by angiography. The results of these investigations indicated that patients with CAD and a plasma cholesterol concentration less than 5.2 mmol l-1 exhibited an increase in plasma triglyceride concentration and a decrease in plasma HDL-cholesterol concentration. Since these subjects were not diabetic, hypertensive or hypercholesterolaemic, it is suggested that the observed changes in triglyceride and HDL metabolism made a major contribution to the CAD in these individuals.